← Eichor
Study identifier: NCT02803242 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

COPD Patient-Powered Research Network

Condition: Chronic Obstructive Pulmonary Disorder · Chronic Obstructive Lung Disease · Emphysema  ·  Sponsor: COPD Foundation

PhaseN/A
Planned participants75000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

The COPD Patient-Powered Research Network (COPD PPRN) is a patient research registry with the goal of enrolling 75,000 or more COPD patients and those at risk who are willing to share their heath information over several years and participate in research. The COPD PPRN has built an online platform to allow volunteers to enroll electronically, complete surveys, be contacted about studies they qualify for and become connected to COPD resources. The goal of the registry is to speed research to find better treatments for COPD and ultimately a cure.

This description comes directly from the study's public registry record.

Talk to the study team

Gretchen M McCreary, MA  ·  866-731-2673  ·  gmccreary@copdfoundation.org

Elisha Malanga  ·  866-731-2673  ·  emalanga@copdfoundation.org

Always discuss trial participation with your own doctor first.

Locations (1)

COPD FoundationWashington D.C., District of Columbia, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02803242